Antibiotics are classified into classes for these purposes: Class A is the drugs for which there is currently no evidence linking the particular bacteria or viruses causing the symptoms. Usually the bacteria (usually in the case of common cold disease and strep throat) causing the symptoms are the same or close in sequence to the antibiotics. Such antibiotics are used clinically during an infectious illness. They are used by clinicians when treating patients with recurrent infections of the upper respiratory tract or for the prevention and treatment of severe or recurrent infections of the upper respiratory tracts (common cold and strep throat). Class B drugs are used for the prevention of bacterial infection in the host (common cold and strep throat). These antibiotics are used clinically for bacterial disease in patients with a chronic or severe infection of the respiratory tract such as recurrent infections of the respiratory tract. They may also be used by children in school due to their immune deficiency. Class C drugs are used to treat acute bacterial infections which, in turn, cause systemic illness that The first generation of modern antibiotics took place in the 19th century with the introduction of penicillin and chloramphenicol. Both penicillin and chloramphenicol have been developed to help control the staphylococcus aureus which forms the majority of skin infections. In the 1900s this group of bacteria had evolved resistance to penicillin which eventually killed it, and so chloramphenicol was developed. In the early 1950s however, the development of antibiotics of the cephalosporins and sialic acid resulted in a growing number of antibiotic-resistant organisms and by 1960 the term "antibiotic resistance" had been coined. The rapid increase in the number of new antimicrobial agents was linked to the increasing use of ciprofloxacin, a treatment for malaria which had been developed by the UK government. It was during this critical period that new antimicrobials were developed such as chloramphenicol, chloramphenicol sulfate (which is also used as an antiseptic), and sialic acid (which was then the name for chloramphenicol sulfate). All the antibiotics used to fight malaria are of cephalosporin properties including those with carbapenems, trachomods, carbapenems in the urease class, and chloramphenicol sulfate. Antibiotics against other types of bacteria can be used but many antibiotics are only used to fight specific infections. Antibiotics can be added to a broad-spectrum solution or have a broad range of effects. For example, chloramphenicol sulfate is helpful in treating anemia but not pneumonia (Pazdah) as used by the US. If a patient is symptomatic but has no other serious problems such as pneumonia, other antibiotics are used instead. These include antibiotics like ciprofloxacin, doxycycline and piperacillin A. Antibiotic resistance is the most common cause of clinical antibiotic failure. Over time, as antibiotic-resistant bacteria evolve resistance to one or more of the antibiotics, more and more drugs are needed. The number of drugs used and the time needed to develop and distribute them has decreased. Also, once they have been approved they tend to have relatively short half-lives. This is because resistance develops to the drugs very quickly. A drug becomes dangerous before its effective life has passed. Also, drugs can be introduced into an antibiotic-resistant population After several months the drug therapy is resumed. The reason for an end to an antibiotic is because there is no chance of recurrence of the infection (prophylaxis) if used within several months. , which is administered in the context of therapy. The term therapeutic may refer to an individual therapy that may, but is not necessarily, limited to the treatment of symptoms and symptoms alone; therapeutic use may include the administration of an additional therapy to help decrease or decrease the symptoms of the previous one. A treatment may require a significant amount of time after the end of a prior one to reduce or prevent symptoms. The same symptoms may result in different symptoms if not treated. Antibiotic therapy does not last completely; that is to say, another antibiotic may have to be administered. The length of time between treatments is dependent on various factors. The duration of antibiotic therapy may vary depending on the type of infection, the level of resistance acquired against an antibiotic, and the severity of the infection. A period between two consecutive antibiotics may be considered a 'period of antibiotic susceptibility'. These may mean the onset of resistance that is present before the cessation of treatment and may not persist. In addition, in some cases (the first year after exposure, for example), a short or temporary improvement in the immune system can persist even after the antibiotics are stopped. ) which is administered in the context of therapy. The term may refer to an individual therapy that may, but is not necessarily, limited to the treatment of symptoms and symptoms alone; therapeutic use may include the administration of an additional therapy to help decrease or decrease the symptoms of the previous one. A treatment may require a significant amount of time after the end of a prior one to reduce or prevent symptoms. the same symptoms may result in different symptoms if not treated. Antibiotic therapy does not last completely; that is to say, another antibiotic may have to be administered. The length of time between treatments is dependent on various factors. The duration of antibiotic therapy may vary depending on the type of infection, the level of resistance acquired against an antibiotic, and the severity of the infection. A period between two consecutive antibiotics may be considered a 'period of antibiotic susceptibility'. Antibiotic therapy is administered with the aid of an outpatient clinic or hospital setting. Medications used for antibiotic prevention include anti-nitzan, theophylline, aminoglycosides (amino acids which bind and inhibit an enzyme called aminoglycosidase which converts lysine to its active Antibiotic Therapy Antibiotic Therapy is a means whereby treatment is initiated, and may also be referred to as therapeutic intervention. Antibiotic therapy involves the administration of a therapeutic agent to an individual or to the body of another person. The effective treatment of an infection is normally achieved when the therapeutic agent is given intravenously. Antibiotics may be administered intravenously, orally in a small quantity, or intravenously by the intravascular route. Antibiotics may be administered either singly or in combination. There are a number of therapeutic agents for the relief of acute bacterial infections. These include oral azithromycin, ampicillin, tetracycline, quinidine, ciprofloxacin, daptomycin, metronidazole and erythromycin. It has also been suggested that some drugs that are currently used do not work so well against certain bacterial pathogenic microorganisms. In addition to such drugs, drugs that are used as antimicrobial agents may have several additional effects, such as preventing resistance to some compounds, or preventing the growth of bacteria in certain environments. In addition, some oral medications may have effects not only when administered intravenously at a dose sufficient to cause a specific reaction, but may also affect other important systems or organs such as the liver and kidneys. Also known as antibiotic prophylaxis, antibiotics provide a broad range of symptomatic treatments. (Tetracycline) How To Treat Infected Humans? How do people get infected? Humans are very susceptible to infection, even some animals, and these are by far the major reasons why they are sometimes referred to as the "sinkers." Infectious disease that results from animal bites is common with dogs (especially those that can be seen from the back window or through windows) and human bites are caused by close contact with dogs. Infected pets are usually given antibiotics or their feces to help prevent infection. Humans are also not the only sources of infection. Humans are considered highly susceptible to infection as a result of being exposed outdoors in an uninsulated room with the windows closed, having food contaminated, and being alone in warm weather (which increases the risk of being infected). Most common sources of human infection are the dog and cat, and other animals. The only reason that the number of people infected is decreasing is that there are fewer pets, more people are changing their lifestyles and becoming more aware of their immune systems, and there are a greater number of hospitals and Usually the treatment has no clinical benefit or a failure rate is over 90% which requires emergency treatment. Some people may continue their treatment even though the symptoms are not improving. The time in between treatment and a successful result is usually short. The long-term effectiveness of antibiotics also tends to depend on the amount of evidence they have to treat. Although some are still used, it tends to be considered unnecessary for most, and they tend to be replaced with newer or less effective drugs. Treatment of common bacterial infections also involves the administration of new drugs that block growth and activity of bactericidal cells. The drug can inhibit both growth and activity of the bactericidal cells. Once you find the agent or agents that are used for this type of work, then you will be able to determine if they are effective. Antibiotics are usually given in a single dose and then discontinued from a continuous basis at regular intervals because they are rarely absorbed effectively. When we examine the efficacy of a drug for treating any disease, we want to know if it is effective against a certain disease, such as a cancer. If the benefit of the antibiotic is due solely to a drug's activity against bacteria, we will call it an anti-antibiotic drug. Antibiotics are highly effective in preventing bacterial infections, particularly when applied to people rather than viruses. The best part about being able to prevent bacterial infections is not having to give antibiotics. We generally use them for a variety of diseases. Antibiotics are frequently prescribed for common infections, such as pneumonia and ear infections. There is little research to say whether they are effective against viruses, but they were widely used in the treatment of chickenpox. Most viruses are harmless to mammals. The only reason it seems to be effective with humans is if given to rabbits, swine or other animals as a vaccine. They are also available for use in humans for various medical conditions. Antibiotics kill some germs. Most germs are harmless (i.e. they do not cause disease). Some germs, such as bacteria, are difficult to kill, or may even make things worse such as cancer. If a treatment is not effective, it may be because it does not kill what is being killed. Some pathogens have a protective effect against antibiotics, such as viruses, but this usually affects only a small number of germs. Although it is possible to give antibiotics to someone on a limited daily basis, the longer it takes to die, the greater the chances that antibiotics could pass into the bloodstream and cause complications. This effect This could be combined with other antibiotics, and often will be administered within three days. Antibiotics are used against a wide variety of bacterial and fungal infections, and their use in humans should always be carefully evaluated by a healthcare professional. Antibiotics are used for some types of bacterial infections or against some infectious agents which may not be fully understood by current diagnostic equipment. Antibiotic use (e.g. when no antibiotics are available or when the patient has been previously treated) may be appropriate only if: 1. The patient's risk is considered to be very low; and 2. The potential of the antibiotic to be effective is not known (eg. antibiotic-treated infections). The patient is to be informed that: 1. In cases of suspected infection a standard first course consisting of a single antibiotic will be begun if required. 2. In emergencies the patient should be given: a) the recommended full course of antibiotics immediately but not longer than 48 hours unless the patient has been previously treated for the disease. b) the full course with antibiotics only if the patient is suspected of being infected through contact with another patient. 3. A second course of antibiotics should be started at the patient's request if prescribed. Antibiotics should not be started for a third course in a patient who has been previously treated minocycline for any condition; however, this does not exclude the choice of other procedures, (eg. chest x-ray in situations without the need of antibiotics) if such an alternative would not be suitable. Antigen identification is the process of comparing the antibodies present in various samples of a patient to the clinical evidence and to his personal history of the presence of the disease. The antigen can include: a. Antibodies to the bacteran species that is causing the infection; b. Antibodies to viruses such as Haemophilus influenza B, Salmonella enterica, Shigella spp., Shigella trachomatis etc. c. Antibodies specific for the specific pathogens of particular bacteria; d. Antibodies specific for the presence of specific organisms such as viruses and fungi; e. Antibodies specific for the presence of various bacteria in one area of the body; and f. All of the above. The following are examples of antigen detection techniques: The patient should be advised of those tests that the healthcare professional uses that, in particular, include: a These tests generally include: Evaluating the clinical signs and symptoms of a typical case Computing a clinical dose of antibiotics for an empiric approach Monitoring the patient during the entire treatment process This type of empiric therapy is usually offered once an illness causes symptoms or signs thought to be related to the underlying disease (sickness, fever, cough, headache). Antibiotics that may also be indicated include the following: Methicillin-resistant Staphylococcus aureus (MRSA) Herpes simplex virus type 2 (HSV-2) Viral hepatitis Infections such as sepsis or hepatitis B Pancreatitis In some cases the illness leads to dehydration, shock or organ failure. If there are systemic symptoms or organ damage, an empiric or palliative approach may be considered. This might include one approach involving one or two antibiotics in addition to fluids and oral antibiotics in case the patient's symptoms and condition do not improve. Palliative methods include intravenous fluids for the treatment of respiratory infections, palliative care, or in addition to fluid delivery of fluids. If the patient seems to be able to tolerate the fluid-only option, then one or more IV fluids might be used. Antibiotics also can be given as intrathecal, intramuscular (intramuscular injection of a single drug over an open wound), or intradital medication on an outpatient basis (i.e., in hospital). Other medications that may be used include a proton pump inhibitor (PPI), a drug called triclosan that can be given as antispasmodic therapy (see Treatment Guidelines for a list of drugs which can be administered to patients for the treatment of chronic conditions). The treatment approach and medications for patients who take antibiotics or anti-toxin agents and other anticoagulants would include follow up visits with the patients' healthcare providers to provide continuing documentation of all the medications, including the history of the dose of each drug and for the frequency of the dose, so that the dose can be monitored under care. Antimicrobials are used to treat a host of infections and can be used by many populations. Antibiotics can also be used to control pathogens that are common to multiple types of bacteria or fungi. Drugs can be used for a variety of applications. They can be given for: Treatment of infectious diseases Fungicidal medicine Immune medicine The patient has to be awake, not febrile, not lethargic, and be stable on intravenous therapy. The recommended duration of therapy is 48 hours. The first dose of therapy is to treat the patient to a dose that is likely to be safe, effective, and effective. The first 24 hours are spent in the intensive care unit, where there are minimal risk of infection. Medication is then transferred to a second set of patients for further evaluation and monitoring. Treatment is continued if necessary, provided adequate protection remains. All patients with suspected bacterial meningitis are routinely considered medically stable, and treatment initiated immediately, including initial antibiotic therapy and additional therapy until a more complete or complete response is demonstrated. At no time is therapy initiated more than 36 hours after admission to the intensive care unit. For patients who have no fever and appear to be stable on anti-parasite therapy, antibiotics should not be administered until further evaluation proves that resistance to the active agent has not developed. However, since the emergence of a disease, resistance to other types of antibiotics may be encountered, so that initiation of such therapy may require 24 to 48 hours. In some situations, an oral antimicrobial may prevent the spread of infection with an organism other than pathogen. In those instances, when an oral antimicrobial is indicated for the purpose of controlling, eliminating as described, or preventing secondary infections caused by the same or a similar agent, a preservative-free, non-hormonal solution (with an effective level of antimicrobial activity) should be used. The preservative-free, non-hormonal solution does not create a bacterial or viral reservoir and may also prevent the spread of infections and cause an increased risk of infection. The preservative-free, non-hormonal solution should not be used within 24 to 36 hours of treatment, even if an initial course of antimicrobials does not result in symptoms or infections. Preservers and manufacturers can provide a "cure" for viral meningitis that is not accompanied by fever, as described in the next section. In the following examples, oral antimicrobials are described based on the clinical course and clinical manifestations.